Can a simple drink help blood cancer patients recover from stem cell transplants?

NCT ID NCT05460013

Completed Disease control Sponsor: RenJi Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a special oral nutritional supplement (Ensure Complete) could help patients with blood cancer maintain weight and gut health after a stem cell transplant. One hundred participants were randomly assigned to receive either the supplement or a standard hospital shake for 7 days before transplant until discharge. The main goal was to see if the supplement reduced weight loss at 28 days after transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Oral nutritional supplement (Ensure Complete)
What this could lead to: If it works, this could show that a simple nutritional drink helps patients maintain weight and gut function during stem cell transplant recovery.
What could go wrong: This is a small, single-center study with only 100 participants. The supplement may not significantly improve outcomes, and some patients may not tolerate it well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMATOLOGICAL MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body Weight hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAEMATOLOGICAL MALIGNANCY

Contacts and locations

Locations

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, 200124, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.